Username:
Password:
Forgot Password?
Remember me
Decade: 2010-2010 2000-2009 1990-1999 1980-1989 1970-1979
Year: 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Issues: Vol. 102 No. 12 December 22, 2008 p.1L-50L-Supplement Vol. 102 No. 12 December 15, 2008 p.1577-1746 Vol. 102 No. 11 December 1, 2008 p.1427-1576 Vol. 102 No. 10 November 17, 2008 p.1K-36K-Supplement Vol. 102 No. 10 November 15, 2008 p.1285-1426 Vol. 102 No. 9 November 3, 2008 p.1J-38J-Supplement Vol. 102 No. 9 November 1, 2008 p.1119-1284 Vol. 102 No. 8 October 15, 2008 p.957-1118 Vol. 102 No. 8 October 12, 2008 p.1I-270I-Supplement Vol. 102 No. 7 October 1, 2008 p.797-956 Vol. 102 No. 6 September 22, 2008 p.1H-32H-Supplement Vol. 102 No. 6 September 15, 2008 p.649-796 Vol. 102 No. 5 September 8, 2008 p.1G-68G-Supplement Vol. 102 No. 5 September 1, 2008 p.509-648 Vol. 102 No. 4 August 15, 2008 p.375-508 Vol. 102 No. 3 August 1, 2008 p.249-374 Vol. 102 No. 2 July 15, 2008 p.115-248 Vol. 102 No. 1 July 1, 2008 p.1-114 Vol. 101 No. 12 June 16, 2008 p.S1-S2-Supplement Vol. 101 No. 12 June 15, 2008 p.1683-1810 Vol. 101 No. 11 June 2, 2008 p.S1-S116-Supplement Vol. 101 No. 11 June 1, 2008 p.1523-1682 Vol. 101 No. 10 May 22, 2008 p.S1-S86-Supplement Vol. 101 No. 10 May 15, 2008 p.1373-1524 Vol. 101 No. 9 May 1, 2008 p.1219-1372 Vol. 101 No. 8 April 23, 2008 p.S1-S108-Supplement 2 Vol. 101 No. 8 April 17, 2008 p.S1-S62-Supplement Vol. 101 No. 8 April 15, 2008 p.1073-1218 Vol. 101 No. 7 April 1, 2008 p.911-1072 Vol. 101 No. 6 March 15, 2008 p.747-910 Vol. 101 No. 5 March 1, 2008 p.557-746 Vol. 101 No. 4 February 15, 2008 p.419-556 Vol. 101 No. 3 February 4, 2008 p.S1-S96-Supplement Vol. 101 No. 3 February 1, 2008 p.279-418 Vol. 101 No. 2 January 15, 2008 p.139-278 Vol. 101 No. 1 January 1, 2008 p.1-138
The State of Coronary Stenting: Reviewing the Evidence & Experience with Drug-Eluting & Bare Metal Stents
20 October 2007 - 25 October 2007
Edited by David G. Rizik MD
Publication of these proceedings were supported by an educational grant from Cordis.
Search Within This Issue
8 Articles:
The State of Coronary Stenting: Reviewing the Evidence & Experience with Drug-Eluting & Bare-Metal Stents
For >2 decades, the field of percutaneous coronary revascularization has been rapidly evolving. This is especially true as it relates to coronary stenting and, specifically, to the use of drug-elut...
Within labeled indications, drug-eluting stents (DES) are as safe as bare-metal stents (BMS). Data from key randomized, controlled trials comparing paclitaxel-eluting stents with BMS or sirolimus-elut...
A well-publicized presentation at the 2006 meeting of the World Congress of Cardiology (WCC) raised questions about the safety of drug-eluting stents (DES), leading to a rapid change in clinical pract...
Accumulating data on the safety and efficacy of first-generation drug-eluting stents (DES) show a favorable risk/benefit profile compared with bare-metal stents (BMS). A recently reported collaborativ...
Although the benefits of drug-eluting stents for the treatment of native coronary lesions in patients undergoing percutaneous coronary interventions have been demonstrated in multiple clinical trials,...
Resistance to the antiplatelet effects of both aspirin and clopidogrel is common and is associated with poorer clinical outcomes in patients receiving antiplatelet therapy. Available data indicate tha...
